Pascale Ehouarn - DBV Technologies Industrial Development and Production Director

Director

Ms. Pascale Ehouarn serves as Industrial Development and Production Director at DBV Technologies SA since 2006. She participates in the development of processes and machine design, and is responsible for the production of pharmaceutical patches for allergy desensitization. With a PhD in Plasma Physics from the University of Paris XI, she completed her thesis and then did a valuation study at Supelec on the electrospray process of water assisted by electrical discharges, in collaboration with EDF. She also completed a postdoctorate at the University of Karlsruhe in Germany, on the packaging of nanopowders by shock, in partnership with BASF. She then secured a position as an RD Project Manager, France Unaxis, Displays Division, in charge of particulate contamination control in production systems by plasma deposition of thin films by PECVD and PVD sites in Taiwan. She is a member of the Directors Committee. since 2006.
Tenure 18 years
Phone33 1 55 42 78 78
Webhttps://www.dbv-technologies.com

DBV Technologies Management Efficiency

The company has return on total asset (ROA) of (31.96) % which means that it has lost $31.96 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (67.72) %, meaning that it generated substantial loss on money invested by shareholders. DBV Technologies' management efficiency ratios could be used to measure how well DBV Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 4.63 M in total debt with debt to equity ratio (D/E) of 0.06, which may suggest the company is not taking enough advantage from borrowing. DBV Technologies has a current ratio of 3.4, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DBV Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, DBV Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DBV Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DBV to invest in growth at high rates of return. When we think about DBV Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Juan VazquezCementos Pacasmayo SAA
N/A
Joaquin GubbinsCementos Pacasmayo SAA
N/A
Diego ApalateguiBBB Foods
47
John BientjesFlexible Solutions Internationa
66
Hugo CastilloCementos Pacasmayo SAA
62
Toru MurayamaFast Retailing Co
63
Carlos MateoCementos Pacasmayo SAA
N/A
Dionisio RomeroCementos Pacasmayo SAA
51
David FynnFlexible Solutions Internationa
61
Alfredo UmlauffCementos Pacasmayo SAA
N/A
Alejandro DavilaBBB Foods
46
Donald WinterMinerals Technologies
72
Marc RobinsonMinerals Technologies
59
John CarmolaMinerals Technologies
65
Toru HambayashiFast Retailing Co
80
Carolyn PittmanMinerals Technologies
57
Robert ClarkMinerals Technologies
57
Felipe MadueoCementos Pacasmayo SAA
72
Ben SeamanFlexible Solutions Internationa
38
Nestor AnguloCementos Pacasmayo SAA
N/A
Joseph BreunigMinerals Technologies
59
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. Dbv Technologies is traded on OTC Exchange in the United States. DBV Technologies SA [DBVTF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

DBV Technologies Leadership Team

Elected by the shareholders, the DBV Technologies' board of directors comprises two types of representatives: DBV Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DBV. The board's role is to monitor DBV Technologies' management team and ensure that shareholders' interests are well served. DBV Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DBV Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Pascale Ehouarn, Industrial Development and Production Director
Claude Thebault, Medical Director
Wence Agbotounou, Chief Clinical Trial Officer
Laurent Martin, Director of Regulatory Affairs
Viviane Monges, Director
Didier Hoch, Director
Hugh Sampson, Chief Scientific Officer
Charles Ruban, Chief Development Officer
Nathalie Donne, Director of Bus. Devel. and Corporate Communication
Lucie Mondoulet, Director of Research Department
Chahra Louafi, Director - Representative of CDC Entreprises (Innobio)
Peter Hutt, Independent Director
Rafaele Tordjman, Director - Representative of Sofinnova Partners
Bertrand Dupont, Co-Founder and Sr. Executive VP of Technology
Veronique Foutel, Director of Strategic Marketing
FAAAAI MD, Chief Scientific Officer, Advisor and Member of The Scientific Advisory Board
Daniel Tasse, CEO, Director
Rafale Tordjman, Director - Representative of Sofinnova Partners
Joan Schmidt, Executive Vice President General Counsel
George Horner, Director
Torbjorn Bjerke, Independent Director
Pharis Mohideen, Chief Medical Officer
PierreHenri Benhamou, Chairman of the Board, CEO
Torbjrn Bjerke, Independent Director
Mailys Ferrere, Director
Michel Rosen, Director
David Schilansky, COO

DBV Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is DBV Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DBV Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DBV Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to News Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace News Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back News Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling News Corp A to buy it.
The correlation of News Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as News Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if News Corp A moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for News Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in DBV OTC Stock

If you are still planning to invest in DBV Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DBV Technologies' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites